
Sarah de Ferranti, MD, director of the Preventive Cardiology Clinic at Boston Children’s Hospital, explained that what is controversial about the National Heart, Lung, and Blood Institute’s most recent set of guidelines addressing lipid screening in children is the call for universal screening at 2 time points: between 9 and 11 years of age and again between 17 and 21 years of age. “This represents a change in practice,” she said in a session titled “Universal lipid screening: Are pediatricians doing it and how is it working?” held on Monday.